Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Chemistry World September 3, 2009 Sarah Houlton	New HIV vaccine hope A team of scientists in the US has discovered two new antibodies that could lead to an HIV vaccine.
BusinessWeek April 12, 2004 Catherine Arnst	Killer Staph Is Hitting The Streets For the past 30 years, hospitals have been battling a mutant form called methicillin-resistant S. aureus (MRSA) that is resistant to penicillin-related antibiotics and is especially lethal. Now it's showing up in the general population.
Chemistry World September 2, 2007 Simon Hadlington	Sweet Approach to Tackling Cancer A promising new 'slimline' cancer vaccine that triggers a powerful immune response against excessive sugar molecules has been unveiled by researchers.
Reactive Reports Issue 58	Anthrax Detector Researchers have developed a detector for anthrax spores based on a monoclonal antibody that recognizes a specific sugar on the bacterium. It might be possible to use this discovery to develop a passive immunization method.
Chemistry World July 8, 2010 Sarah Houlton	Antibodies spark HIV vaccine hopes These cross-reactive broadly neutralising antibodies bound to and neutralised more than 90 per cent of the HIV strains they were tested against.
Chemistry World November 19, 2009 Hayley Birch	How HIV gives antibodies the slip New research helps explain why antibodies designed to disarm HIV don't work unless they hit their target spot on.
Chemistry World February 5, 2014 Jenifer Mizen	Protein-free and low sugar -- not a new diet, a new vaccine A Streptococcus pneumonia vaccine with fewer sugar units and no antigenic protein is not only easier to produce but could also induce a superior immune response to the vaccine currently in clinical use.
Chemistry World August 3, 2006 Bea Perks	Sugar-Coated Antibodies The fate of the prey captured by our body's guardian antibodies can be determined by sugar molecules found on the antibody's surface. The news has come as a surprise to immunologists, who were unsure of these sugar molecules' exact role.
The Motley Fool August 31, 2011 Brian Orelli	Antibodies: They're Not Just for Fighting Infection Anymore Therapeutic antibodies have continued to evolve since the first, OKT3, was approved back in 1986. Biotech investors had better pay attention, lest the technology passes them by.
Chemistry World March 15, 2012 Andrew Shore	Designer solvent hits hospital superbug Scientists from Ireland, the Czech Republic and Spain have found an antimicrobial ionic liquid that targets MRSA (methicillin-resistant Staphylococcus aureus).
Chemistry World April 2, 2013 Emma Stoye	New diagnostic test lights up bacteria UK researchers have developed a faster way to detect Staphylococcus aureus bacteria using a fluorescent probe. The method holds promise as the basis for a new rapid diagnosis kit to identify infections in hospital patients.
Nursing Management October 2010 Spencer & Gulczynski	Cut down on SSIs Some surgical candidates may present with asymptomatic colonization with methicillin-resistant Staphylococcus aureus and methicillin-sensitive Staphylococcus aureus, risk factors for surgical site infections.
Pharmaceutical Executive December 1, 2010 Walter Armstrong	Vaccines: Progress in Preventing Bad Bugs Long on the sidelines of pharma R&D, vaccine development is moving to center stage as most of the big pharmas diversify, spreading their risk among the full gamut of revenue sources.
Fast Company May 2009 Elizabeth Svoboda	Biotechs Wage War on Superbugs With antibiotic resistance on the rise, three biotechs are developing new ways to wage war on superbugs.
Chemistry World September 19, 2008 John Bonner	Filling the antibiotic gap Resistance to currently available antibacterial drugs is causing growing concern among doctors who find themselves unable to treat common infections
Wired January 2003 Richard Martin	Testing the First AIDS Vaccine Medical establishment, government, and Genentech be damned -- Don Francis has never stopped believing. Now he's about to finish testing the first human AIDS vaccine.
Chemistry World August 18, 2011 Helen Bache	Sugar injection to beat hospital infection A carbohydrate from the surface of the most virulent strain of the bacterium Clostridium difficile has been synthesised by chemists in Germany. The molecule could be used to develop a vaccine against the infection.
Chemistry World December 3, 2014 Maria Burke	Ebola vaccine passes first safety hurdle The vaccine was developed collaboratively by scientists at the NIH's National Institute of Allergy and Infectious Diseases, and at Okairos, a biotechnology company acquired by GlaxoSmithKline.
Chemistry World July 19, 2013 Daniel Johnson	Dipstick test for plague on the way Plague could soon be diagnosed faster than ever before, thanks to scientists in Germany. The group have pioneered a new, dipstick test which will drastically cut the time it takes to spot the disease.
Chemistry World March 9, 2012 Fiona McKenzie	Cleaning up antibodies for disease studies A polymer functionalized with boronic acid promises a cheap and quick way to purify antibodies for disease studies, according to scientists in China.
Scientific American April 10, 2006 Christine Soares	Turning Yellow Yellow fever shot confers long-lasting immunity, a trait that medical researchers hope to transfer to other kinds of vaccines.
Chemistry World April 4, 2011 Carol Stanier	Mighty micelles that make themselves Scientists in the US and Singapore have made self assembling micelles of cationic polymers that kill bacteria but are biodegradable - raising further hope of a nanotechnology solution to the problem of antibiotic resistance.
Chemistry World August 2, 2012 Yuandi Li	Cleaning hands with light A quick way to kill methicillin resistant Staphylococcus aureus and other pathogens using a photosensitiser and visible light can be used to clean hands, say scientists in Germany.
The Motley Fool January 3, 2008 Brian Orelli	A Super Superbug Testing Market Becton, Dickinson gets FDA approval of its quick blood test for MRSA, the so-called superbug.
Chemistry World August 20, 2014 Maria Burke	Doctors turn to experimental Ebola treatments The emergency use of an experimental medicine is highly unusual, but the WHO has declared the Ebola outbreak a public health emergency of international concern.
Chemistry World March 3, 2009 Lewis Brindley	Sweet-toothed bacteria make their own vaccine With careful feeding, bacteria can produce vaccines against themselves, scientists in the US and China have found.
HHMI Bulletin Feb 2012 Nancy Ross-Flanigan	A Safer Shot at TB While trying to understand tuberculosis bacteria genes, researchers discovered a safe way to shut down the bacteria.
Chemistry World January 29, 2015 Matthew Gunther	Ebola vaccine shown to be safe in humans GlaxoSmithKline's experimental Ebola vaccine is capable of triggering an immune response in humans, according to a new study.
Chemistry World September 4, 2006 Michael Gross	Antibodies in the Greenhouse Researchers have developed a way to produce molecules of the antibody class immunoglobulin G (IgG) in the leaves of ordinary tobacco plants.
Chemistry World December 7, 2012 Lucy Gilbert	Bactericides reach new depths Scientists in the US and China have come up with a low-risk treatment for bacterial infections in a deep wound.
Popular Mechanics September 2006 Ben Harder	Seeking Immunity Pathogens like West Nile virus show no respect for borders. But a new class of vaccines may soon keep them in check.
American Family Physician December 15, 2005 Bamberger & Boyd	Management of Staphylococcus aureus Infections Because of high incidence, morbidity, and antimicrobial resistance, Staphylococcus aureus infections are a growing concern for family physicians.
AskMen.com	Vaccine Helps Prevent HIV For the first time, an experimental vaccine has prevented infection with the AIDS virus, a watershed event in the deadly epidemic and a surprising result.
The Motley Fool September 29, 2004 Charly Travers	Nabi Stamps Out Smoking A nicotine vaccine looks to help smokers kick the habit.
Science News March 1, 2003 Ben Harder	Bacteria-Stocked Beverage Clears Pathogens from Nose Considerable evidence indicates that ingesting certain bacteria, called probiotics, can maintain or improve intestinal health. Some researchers have also examined whether these bacteria could aid health in other parts of the body.
Chemistry World February 22, 2010 Hayley Birch	Soil switches on antibiotic genes in bacteria So-called 'cryptic' bacterial genes that preside over the production of medically important compounds can be switched on using environmental triggers, German scientists have shown.
The Motley Fool October 1, 2008 Brian Orelli	3 Drugmakers With Multiple Shots on Goal Well-stocked pipelines could kick these drugmakers into super-high gear.
Nursing Management May 2009 Dawn M. Pope et al.	MRSA Reduction: Myths and Facts To prevent the spread of MRSA, organizations must commit to implementing evidence-based guidelines and providing ongoing education to address misconceptions and individual attitudes.
Chemistry World July 25, 2008 Olivia Walker	Engineered antibodies could cut chemotherapy risks US scientists have cut the side-effects of cancer treatment in animal trials by carefully controlling the number of drug molecules attached to the antibodies used for chemotherapy.
The Motley Fool May 8, 2009 Brian Orelli	Glaxo Goes Head-to-Head on HPV Glaxo's data may not be enough to help Cervarix knock Merck's Gardasil from the top papillomavirus vaccine spot.
Reactive Reports Issue 73 David Bradley	Gator Aid It's perhaps not the first place you would think to search for superbug-beating antibiotics, but alligator's blood could be a great source of novel compounds that could defeat strains of bacteria resistant to conventional antibiotics.
The Motley Fool September 24, 2009 Brian Orelli	Drugmakers' HIV Treatments Live On Companies that make HIV drugs could lose billions of dollars in revenue if an effective vaccine is developed. All drug-company investors need to keep an eye on up-and-coming drugs from competitors that could take market share.
Fast Company August 8, 2011 Kate Rockwood	AIDS Vaccine Conference Despite billions in annual research dollars, the quest for an AIDS vaccine remains elusive.
AskMen.com Jacob Franek	Superbugs So long as antibiotic use remains widespread and excessive, superbug bacteria will be here with us. Read on about some of the most common North American superbugs.
Chemistry World October 2, 2012 Andrew Turley	Merck & Co $460m ion channel deal Merck & Co has struck a $460 million deal for rights to certain drug candidates developed by Belgian pharma company Ablynx. Merck will get rights to the monoclonal antibodies found to target a voltage gated ion channel.
Health June 19, 2009 Ginny Graves	How to Combat the Latest Supergerms While some germs may be outpacing our ability to kill them, we're not completely defenseless. In fact, there are plenty of things we can do to slow their spread.
Chemistry World December 4, 2009 Lewis Brindley	Potent two-pronged antibiotic provides hope for future drugs A two-headed compound obtained from soil bacteria may hold the key to developing the next generation of antibiotics, researchers in the UK report.
Chemistry World July 29, 2015 Maria Burke	Malaria vaccine approval first marred by efficacy question mark After decades of research, a malaria vaccine has finally been given the green light by a regulatory agency. But with limited efficacy and questions over the vaccine's cost, its future remains unclear.
Scientific American January 2007	Meet Resistance Head-On With resistance to antibiotics growing at an alarming pace among pathogenic bacteria, Americans must become more aggressive with regard to early intervention in the processes that foster resistance.
Chemistry World May 5, 2011 Simon Hadlington	Revolutionary new single-cell labelling method Researchers in the US and Canada have combined mass spectrometry with a technique called flow cytometry to follow dozens of biochemical markers on individual cells simultaneously.